TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 88 filers reported holding TRILLIUM THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $14,929,000 | +83.3% | 850,207 | +1.2% | 0.00% | +100.0% |
| Q2 2021 | $8,146,000 | +905.7% | 839,889 | +1041.7% | 0.00% | – |
| Q1 2021 | $810,000 | -24.5% | 73,562 | +2.9% | 0.00% | – |
| Q4 2020 | $1,073,000 | +383.3% | 71,457 | +356.2% | 0.00% | – |
| Q3 2020 | $222,000 | +59.7% | 15,662 | -9.2% | 0.00% | – |
| Q2 2020 | $139,000 | +101.4% | 17,248 | 0.0% | 0.00% | – |
| Q1 2020 | $69,000 | -67.1% | 17,248 | -91.6% | 0.00% | – |
| Q4 2019 | $210,000 | +577.4% | 205,450 | +100.0% | 0.00% | – |
| Q3 2019 | $31,000 | -6.1% | 102,725 | 0.0% | 0.00% | – |
| Q2 2019 | $33,000 | +94.1% | 102,725 | +285.8% | 0.00% | – |
| Q1 2019 | $17,000 | -81.1% | 26,627 | -50.0% | 0.00% | – |
| Q4 2018 | $90,000 | +55.2% | 53,254 | +428.0% | 0.00% | – |
| Q3 2018 | $58,000 | -3.3% | 10,086 | 0.0% | 0.00% | – |
| Q2 2018 | $60,000 | – | 10,086 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 4,040,000 | $59,428,000 | 8.74% |
| Fairmount Funds Management LLC | 1,478,181 | $21,744,000 | 7.78% |
| COMMODORE CAPITAL LP | 852,871 | $12,546,000 | 6.82% |
| Ghost Tree Capital, LLC | 1,950,000 | $28,685,000 | 6.39% |
| Endurant Capital Management LP | 655,741 | $9,646,000 | 3.48% |
| FRAZIER MANAGEMENT LLC | 3,053,107 | $44,879,000 | 3.46% |
| ACUTA CAPITAL PARTNERS, LLC | 803,000 | $11,812,000 | 3.21% |
| NEA Management Company, LLC | 5,736,363 | $84,382,000 | 2.23% |
| Tri Locum Partners LP | 296,838 | $4,366,000 | 1.59% |
| Avidity Partners Management LP | 3,185,200 | $46,854,000 | 1.52% |